BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Myeloid Cell Determinant of Tumor Immunity
DTSTART:20200326T121500
DTEND:20200326T133000
DTSTAMP:20260430T213230Z
UID:4653db0b49864ee58e58067bde8b09da1fed0183a930dc4ae946f7ed
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Miriam MERAD Department of Oncological Sciences Tisch Ca
 ncer Institute\, Hess Center 5th floor\, Room 118 Icahn School of Medicine
  at Mount Sinai New York\, NY - USA\nA Lola and John Grace Distinguished L
 ecture in Cancer Research\nThis seminar will also be televised to CHUV/AGO
 RA\, Biopôle and Geneva University (rooms tbc)\n\nMy research over the pa
 st 20 years has focused on understanding the mechanisms that control the d
 evelopment and functional identity of tissue resident dendritic cells and 
 macrophages during homeostasis\, and examining how these regulations are c
 hanged in cancer and inflammatory diseases. The overarching goal of my lab
 oratory is to identify dysregulated pathways in macrophages and dendritic 
 cells that can be harnessed to treat Cancer using both genetically enginee
 red mouse models and human lesions to address these questions. To expand t
 he understanding of immune cells contribution to human lesions\, I have fo
 unded in 2009\, the human immune monitoring center at Mount Sinai to imple
 ment technology platforms to maximize information obtained from limited bi
 ological samples. This platform dramatically fostered the use of novel tec
 hnology by Basic and translational immunologists across campus and was rec
 ently awarded a $13M grant award (CIMAC) by the NIH as part of the cancer 
 moonshot to help identify novel mechanisms of resistance to immunotherapy.
  In 2016\, I have taken the leadership of the Precision Immunology Institu
 te at the icahn School of Medicine (PrIISM) to continue to lead initiative
 s to enhance human immunology science. PrIISM integrates immunological res
 earch programs across 42 laboratories with synergistic expertise in biolog
 y\, medicine\, technology\, physics\, mathematics and computational biolog
 y which come together to frame novel questions to understand the contribut
 ion of immune cells to disease initiation\, progression and response to tr
 eatment\, to implement cutting edge technologies and to develop novel immu
 notherapy strategies for the treatment of human diseases.  
LOCATION:SV 1717 https://plan.epfl.ch/?room==SV%201717
STATUS:CANCELLED
END:VEVENT
END:VCALENDAR